Category Archives: Alzheimer’s disease

Detection of early stage Alzheimer’s in blood – Study

Two major studies with promising antibodies have recently failed – possibly because they have been administered too late. A new very early-detection test gives rise to hope.

Using current techniques, Alzheimer’s disease, the most frequent cause of dementia, can only be detected once the typical plaques have formed in the brain. At this point, therapy seems no longer possible. However, the first changes caused by Alzheimer’s take place on the protein level up to 20 years sooner. A two-tier method developed at Ruhr-Universität Bochum (RUB) can help detect the disease at a much earlier stage. The researchers from Bochum published their report in the March 2019 edition of the journal “Alzheimer’s and Dementia: Diagnosis, Assessment and Disease Monitoring”.

 

Blausen_0102_Brain_Motor&Sensory_(flipped)

“This has paved the way for early-stage therapy approaches, where the as yet inefficient drugs on which we had pinned our hopes may prove effective,” says Professor Klaus Gerwert from the Department of Biophysics at RUB.

Continue reading

Leave a comment

Filed under Alzheimer's, Alzheimer's disease, beta-amyloid, dementia

Researchers Define Alzheimer’s-like Brain Disorder

As regular readers know, I have a history of Alzheimer’s Disease or some form of dementia on both sides of my family, so I entertain a strong interest in the subject, particularly since I am a senior citizen.

neuroimaging-social-exclusion-radicalization-neuroscineews

A brain disorder that mimics symptoms of Alzheimer’s disease has been defined with recommended diagnostic criteria and guidelines for advancing future research on the condition. Researchers at Rush University Medical Center and scientists from several National Institutes of Health-funded institutions, in collaboration with international peers, described the newly named pathway to dementia, limbic-predominant age-related TDP-43 encephalopathy, or LATE, in a report published today in the journal Brain.

“We proposed a new name to increase recognition and research for this common cause of dementia, the symptoms of which mimic Alzheimer’s dementia but is not caused by plaques and tangles (the buildup of beta amyloid proteins that Alzheimer’s produces). Rather, LATE dementia is caused by deposits of a protein called TDP-43 in the brain,” said Dr. Julie Schneider, senior author of the Brain paper and associate director of the Rush Alzheimer’s Disease Center. Continue reading

1 Comment

Filed under aging brain, Alzheimer's disease, brain, brain function, dementia

FDA takes action against 17 companies for illegally selling products making Alzheimer’s disease claims

As I have written here numerous times, both sides of my family have a history of Alzheimer’s Disease, the most common form of dementia. As a guy in his late 70’s this is a critical subject for me. And I am not the only one. I live near Northwestern Memorial Hospital, a major Chicago health establishment. They have a Healthy Transitions program there for folks over 50 which provides programs explaining the changes we are experiencing and can expect to experience. The most popular are the ones dealing with cognitive impairment, Alzheimer’s and dementia. We are all concerned.

person holding string lights photo

Photo by David Cassolato on Pexels.com

That’s why I hope there is a special place in hell for companies who prey on the fears of seniors about their mental health and capacities. I found this item from the U.S. Food and Drug Administration (FDA) most satisfying. Continue reading

1 Comment

Filed under aging, aging brain, Alzheimer's disease, Alzheimer's risk, cognition, cognitive decline, dementia, successful aging

How exercise may protect against Alzheimer’s – Study

As a senior citizen whose family has Alzheimer’s and dementia on both sides I am keenly interested in anything on the subject. Herewith a study published in Nature Medicine.

Athletes know a vigorous workout can release a flood of endorphins: “feel-good” hormones that boost mood. Now there’s evidence that exercise produces another hormone that may improve memory and protect against Alzheimer’s disease, according to a study co-led by Ottavio Arancio, MD, PhD, a researcher at Columbia University’s Vagelos College of Physicians and Surgeons and Taub Institute for Research on Alzheimer’s Disease and the Aging Brain.

neuroimaging-social-exclusion-radicalization-neuroscineews

Physical activity is known to improve memory, and studies suggest it may also reduce the risk of Alzheimer’s disease. But researchers don’t understand why. Continue reading

5 Comments

Filed under aging, Alzheimer's disease, Alzheimer's risk, dementia, Exercise, exercise and brain health, exercise benefits, successful aging

Alzheimer’s blood test detects brain damage years before symptoms – Study

A blood test for a protein could identify people in the early stages of Alzheimer’s disease a decade or more before symptoms, such as a decline in memory and thinking, emerge, as reported in Medical News Today.

This was what an international group of scientists concluded after evaluating the simple test that used blood samples from people with a rare form of Alzheimer’s disease that they had inherited.

The team included researchers from Washington University School of Medicine in St. Louis, MO and the German Center for Neurodegenerative Diseases in Tübingen, Germany.

The test looks for changes in levels of the neurofilament light chain (NfL) protein. The protein normally resides inside brain cells, or neurons, as part of their internal skeleton.

person holding string lights photo

Photo by David Cassolato on Pexels.com

However, damaged and dying cells can leak NfL into surrounding cerebrospinal fluid. The protein then travels from the fluid into the bloodstream. Continue reading

2 Comments

Filed under aging brain, Alzheimer's, Alzheimer's disease, blood test, brain, cognition, cognitive decline

Meditation and Music May Alter Blood Markers of Cellular Aging and Alzheimer’s Disease in Adults with Early Memory Loss

A research team led by Dr. Kim Innes, a professor in the West Virginia University School of Public Health, has found that a simple meditation or music listening program may alter certain biomarkers of cellular aging and Alzheimer’s Disease in older adults who are experiencing memory loss. Study findings, reported in the Journal of Alzheimer’s Disease, also suggest these changes may be directly related to improvements in memory and cognition, sleep, mood, and quality of life.

black and white keys music note

Photo by Pixabay on Pexels.com

Sixty older adults with subjective cognitive decline (SCD), a condition that may represent a preclinical stage of Alzheimer’s disease, participated in the randomized, clinical trial. While SCD has been linked to increased risk for dementia and associated with certain neuropathological changes implicated in Alzheimer’s disease development, including elevated brain levels of beta amyloid, this preclinical period may also provide a critical window for therapeutic intervention.

In this trial, each participant was randomly assigned to either a beginner meditation (Kirtan Kriya) or music listening program and asked to practice 12 minutes/day for 12 weeks. At baseline and 3 months, blood samples were collected. Two markers of cellular aging were measured: telomere length and telomerase activity. (Telomeres serve as protective caps on chromosomes; telomerase is an enzyme responsible for maintaining telomere length). Blood levels of specific beta-amyloid peptides commonly linked to Alzheimer’s Disease were also assessed. In addition, memory and cognitive function, stress, sleep, mood, and quality of life were measured. All participants were followed for a total of 6 months. Continue reading

Leave a comment

Filed under aging, aging brain, Alzheimer's, Alzheimer's disease, cognition, cognitive decline, memory, music, music listening, music therapy, successful aging

Alzheimer’s Genetically Linked to Cardiovascular Disease – Study

Studying DNA from more than 1.5 million people, an international team of researchers — led by Washington University School of Medicine in St. Louis and the University of California, San Francisco — has identified points of DNA that increase the risk of cardiovascular disease and also heighten the risk for Alzheimer’s disease, according to an article in Neuroscience News.

neuroplasticity-aging-neuroscinecneews-public

Scientists have long been aware of connections between variations of the APOE gene, which is involved in cholesterol and lipid metabolism, and Alzheimer’s disease. That gene is known to double the risk for Alzheimer’s disease in some patients and increase risk by up to 12 times in others. But in the new study, the researchers identified other DNA points that also appear to be involved both in cardiovascular disease risk and the risk for Alzheimer’s. Continue reading

Leave a comment

Filed under aging brain, Alzheimer's, Alzheimer's disease, Alzheimer's risk, brain, brain function, brain health, dementia, heart health brain health

Cognitive stress test can show high level of beta-amyloid

We are eating less; moving more and hopefully living longer, but it is imperative that we have a fully functioning brain or our work will be in vain.

A simple and inexpensive word recall test accurately predicted whether people had elevated brain levels of beta-amyloid. Scientists hope this non-invasive stress test that puts pressure on memory–similar to how an exercise stress test checks cardiovascular health–could help identify subtle signs of cognitive impairment that may have previously been missed by standard memory tests.

brain

An NIA-supported team of researchers led by Dr. David Loewenstein of the Center for Cognitive Neurosciences and Aging and the University of Miami Miller School of Medicine developed the Loewenstein-Acevedo Scales for Semantic Interference and Learning (LASSI-L) test. Their preliminary findings were published in the September 4, 2018 issue of Neurology.

Continue reading

Leave a comment

Filed under aging brain, Alzheimer's disease, beta-amyloid, brain, brain function, cognition, cognitive decline, dementia

AI Could Soon Predict Cognitive Decline Leading to Alzheimer’s Disease – Study

A team of scientists has successfully trained a new artificial intelligence (AI) algorithm to make accurate predictions regarding cognitive decline leading to Alzheimer’s disease.

Dr. Mallar Chakravarty, a computational neuroscientist at the Douglas Mental Health University Institute, and his colleagues from the University of Toronto and the Center for Addiction and Mental Health, designed an algorithm that learns signatures from magnetic resonance imaging (MRI), genetics, and clinical data. This specific algorithm can help predict whether an individual’s cognitive faculties are likely to deteriorate towards Alzheimer’s in the next five years.

1-brain

“At the moment, there are limited ways to treat Alzheimer’s and the best evidence we have is for prevention. Our AI methodology could have significant implications as a ‘doctor’s assistant’ that would help stream people onto the right pathway for treatment. For example, one could even initiate lifestyle changes that may delay the beginning stages of Alzheimer’s or even prevent it altogether,” says Chakravarty, an Assistant Professor in McGill University’s Department of Psychiatry. Continue reading

Leave a comment

Filed under aging brain, AI, Alzheimer's disease, brain, brain function, brain health, cognition, cognitive decline, Healthy brain, Uncategorized

10 Warning signs of dementia – Infographic

You don’t have to be a senior to suffer from cognitive impairment. Here are some hopefully helpful hints for self-assessment from the Alzheimer’s Association.

Screen Shot 2018-09-06 at 6.08.58 AM.png

2 Comments

Filed under aging brain, Alzheimer's, Alzheimer's disease, brain, cognition, cognitive decline, dementia

Alzheimer’s symptoms may be predicted during eye exam

With three cases of Alzheimer’s Disease or dementia in my family I have serious interest in all variations of cognitive impairment. Hence, this latest work from Washington University School of Medicine.

It may be possible in the future to screen patients for Alzheimer’s disease using an eye exam.

brain

Using technology similar to what is found in many eye doctors’ offices, researchers at Washington University School of Medicine in St. Louis have detected evidence suggesting Alzheimer’s in older patients who had no symptoms of the disease.

Their study, involving 30 patients, is published Aug. 23 in the journal JAMA Ophthalmology. Continue reading

Leave a comment

Filed under aging brain, Alzheimer's, Alzheimer's disease, brain, brain function, brain health, dementia

Alzheimer’s Risk Impacted by Liver, Diet – Study

Reduced levels of plasmalogens—a class of lipids created in the liver that are integral to cell membranes in the brain—are associated with an increased risk of Alzheimer’s Disease, according to new research presented this week at the Alzheimer’s Association International Conference (AAIC) 2018 by Mitchel A. Kling, MD, an associate professor of Psychiatry in the Perelman School of Medicine at the University of Pennsylvania and the Veterans Affairs Medical Center.

person holding string lights photo

Photo by David Cassolato on Pexels.com

Plasmalogens are created in the liver and are dispersed through the blood stream in the form of lipoproteins, which also transport cholesterol and other lipids to and from cells and tissues throughout the body, including the brain. Kling, and the multi-institutional Alzheimer’s Disease Metabolomics Consortium led by Rima F. Kaddurah-Daouk, PhD, at Duke University School of Medicine, developed three indices for measuring the amount of these lipids related to cognition, in order to identify whether reduced levels in the bloodstream are associated with an increased risk of Alzheimer’s disease, mild cognitive impairment (MCI), overall cognitive function, and/or other biomarkers of neurodegeneration in Alzheimer’s disease. The three indices measured: the ratios of plasmalogens to each other; the ratios of plasmalogens to their closely-related, more conventional lipid counterparts; and a combination of these two quantities. Continue reading

Leave a comment

Filed under aging brain, Alzheimer's disease, Alzheimer's risk, brain, brain damage, liver, liver damage

The difference between Alzheimer’s and dementia – Mayo Clinic

I have talked a lot about Alzheimer’s Disease and dementia over the past eight years, so when I ran across this explanation from the Mayo Clinic, I thought I would share it with  you.

These terms are often used interchangeably, but they actually have very different meanings. Dementia is not a specific disease. It’s an overall term, sometimes referred to as an umbrella term, which describes a wide range of symptoms. These symptoms impact a person’s ability to perform everyday activities independently. Common symptoms include:

A decline in memory
Changes in thinking skills
Poor judgment and reasoning skills
Decreased focus and attention
Changes in language and communication skills

screen-shot-2016-09-17-at-1-39-03-pm1.png

Alzheimer’s disease is one type of dementia, but it’s not the only one. There are many different types and causes of dementia, including:

Lewy body dementia
Frontotemporal dementia
Vascular dementia
Parkinson’s disease dementia
Creutzfeldt-Jakob disease
Huntington’s disease
Mixed dementia

Alzheimer’s disease, however, is the most well-known and common form of dementia but not everyone with dementia has Alzheimer’s disease.

Leave a comment

Filed under aging brain, Alzheimer's, Alzheimer's disease, brain, brain damage, dementia

Mediterranean diet could reduce osteoporosis – Study

Eating a Mediterranean-type diet could reduce bone loss in people with osteoporosis – according to new research from the University of East Anglia.

New findings show that sticking to a diet rich in fruit, vegetables, nuts, unrefined cereals, olive oil, and fish can reduce hip bone loss within just 12 months.

vegetable salad with wheat bread on the side

Photo by Dana Tentis on Pexels.com

The study is the first long-term, pan-European clinical trial looking at the impact of a Mediterranean diet on bone health in older adults.

More than 1,000 people aged between 65 and 79 took part in the trial, and volunteers were randomized into two groups – one which followed a Mediterranean diet and a control group which did not.

Bone density was measured at the start and after 12 months. The diet had no discernible impact on participants with normal bone density, but it did have an effect on those with osteoporosis.

People in the control group continued to see the usual age-related decrease in bone density, but those following the diet saw an equivalent increase in bone density in one part of the body – the femoral neck. This is the area which connects the shaft of the thigh bone to its rounded head, which fits in the hip joint.

UK study lead Prof Susan Fairweather-Tait, from UEA’s Norwich Medical School, said: “This is a particularly sensitive area for osteoporosis as loss of bone in the femoral neck is often the cause of hip fracture, which is common in elderly people with osteoporosis.

“Bone takes a long time to form, so the 12-month trial, although one of the longest to date, was still a relatively short time frame to show an impact. So the fact we were able to see a marked difference between the groups even in just this one area is significant.”

The EU-funded trial, led by the University of Bologna, was completed by 1142 participants recruited across five centers in Italy, the UK, the Netherlands, Poland and France. Those following the Mediterranean diet increased their intake of fruits, vegetables, nuts, unrefined cereals, olive oil, and fish, consumed small quantities of dairy products and meat and had a moderate alcohol intake.

People in the intervention group were provided with foods such as olive oil and wholemeal pasta, to encourage them to stick to the diet, and were also given a small vitamin D supplement, to even out the effects of different levels of sunlight on vitamin D status between the participating countries.

At the start and end of the trial, blood samples were taken to check for circulating biomarkers. Bone density was measured in over 600 participants across both groups at the lumbar spine and femoral neck. Of these participants, just under 10% were found to have osteoporosis at the start of the study.

Co-researcher from UEA, Dr Amy Jennings said: “Although this is a small number it is sufficient for the changes in femoral neck bone density between the two groups to be statistically significant.

“Those with osteoporosis are losing bone at a much faster rate than others, so you are more likely to pick up changes in these volunteers than those losing bone more slowly, as everyone does with age.

“With a longer trial, it’s possible we could have picked up changes in the volunteers with normal bone density. However, we already found it quite challenging to encourage our volunteers to change their diet for a year, and a longer trial would have made recruitment more difficult and resulted in a higher drop-out.”

The researchers would now like to see a similar, or ideally longer, trial in patients with osteoporosis, to confirm the findings across a larger group and see if the impact can be seen in other areas of the body. If the condition could be mitigated through diet, this would be a welcome addition to current drug treatments for osteoporosis, which can have severe side effects.

But in the meantime, say the researchers, there is no reason for those concerned about the condition not to consider adapting their diet.

“A Mediterranean diet is already proven to have other health benefits, reducing the risk of cardiovascular disease, Parkinson’s, Alzheimer’s and cancer,” said Prof Fairweather-Tait. “So there’s no downside to adopting such a diet, whether you have osteoporosis or not.”

3 Comments

Filed under Alzheimer's disease, cancer, healthy bones, Mediterranean Diet, osteoporosis, Parkinson's disease

Obesity Plus Aging Linked to Alzheimer’s Markers in the Brain

A new study reports high sugar and fat based diets that lead to obesity, coupled with the normal aging process, may increase the risk of Alzheimer’s disease. By my reckoning that means the older we get the more we need to pay attention to what we are eating and the amount we are exercising. Eat less; move more; live longer. For heaven’s sake, don’t wait till you are a senior to get on the exercise and good eating regime. Clearly, the earlier you start, the better of you are.

A new study suggests that when a high-fat, high-sugar diet that leads to obesity is paired with normal aging, it may contribute to the development of Alzheimer’s disease. In addition, researchers discovered that certain areas of the brain respond differently to risk factors associated with Alzheimer’s. The study is published in Physiological Reports.

photo of head bust print artwork

Photo by meo on Pexels.com

Alzheimer’s disease, the most common form of dementia, is a progressive brain disorder that leads to loss of cognitive skills and memory and causes significant changes in behavior. Aging is a significant risk factor for Alzheimer’s. Previous studies suggest that diet-related obesity is also associated with development of the disease. Continue reading

Leave a comment

Filed under aging brain, Alzheimer's, Alzheimer's disease, Alzheimer's risk, brain, brain function, Exercise, exercise benefits, obesity

Researchers Reverse Cognitive Impairment in Mice with Dementia

If you have been reading this blog for a while you are aware that I have a particular focus on the brain afflictions – dementia and its move common manifestation, Alzheimer’s. Three members on both sides of my family suffered from a form of dementia. While there is no cure or preventative for Alzheimer’s, it seems that exercise is our best chance of possessing a functioning brain in our old age. Hence, my focus on movement of every kind. Now, it seems that we may be getting a new arrow in our quiver to fight mental illness.

Researchers report tau pathology can be reversed in Alzheimer’s patients with the help of a drug. Their study reveals reversing tau pathology in mouse models of dementia resulted in a reversal of cognitive deficits in spatial learning.

tau-dementia-cognition-neurosciencenews-public

Compared with untreated animals, tau mice that had received zileuton performed significantly better on the tests. Their superior performance suggested a successful reversal of memory deficiency. NeuroscienceNews.com image is in the public domain.

Reversing memory deficits and impairments in spatial learning is a major goal in the field of dementia research. A lack of knowledge about cellular pathways critical to the development of dementia, however, has stood in the way of significant clinical advance. But now, researchers at the Lewis Katz School of Medicine at Temple University (LKSOM) are breaking through that barrier. They show, for the first time in an animal model, that tau pathology – the second-most important lesion in the brain in patients with Alzheimer’s disease – can be reversed by a drug.

 “We show that we can intervene after disease is established and pharmacologically rescue mice that have tau-induced memory deficits,” explained senior investigator Domenico Praticò, MD, Scott Richards North Star Foundation Chair for Alzheimer’s Research, Professor in the Departments of Pharmacology and Microbiology, and Director of the Alzheimer’s Center at Temple at LKSOM. The study, published online in the journal Molecular Neurobiology, raises new hope for human patients affected by dementia. Continue reading

1 Comment

Filed under aging, aging brain, Alzheimer's, Alzheimer's disease, Alzheimer's risk, dementia, successful aging